Target intelligence / Profile preview

Microbial enzymes containing reactive cysteine residues

Molecular classification
Enzyme, Cysteine protease, Oxidoreductase, Transferase
01

Overview

Microbial enzymes containing reactive cysteine residues represent a diverse group of proteins essential for the survival, replication, and virulence of various pathogens, including bacteria, viruses, and parasites (Sali et al., 1993). These enzymes utilize the high nucleophilicity of the cysteine thiol group to perform critical catalytic functions, such as peptide bond hydrolysis, redox reactions, and post-translational modifications. In many pathogens, these enzymes are responsible for critical processes such as the processing of viral polyproteins, as seen with the SARS-CoV-2 main protease, or the assembly of bacterial cell walls via enzymes like Sortase A (Jin et al., 2020). Because the reactive cysteine is often indispensable for enzymatic activity, it serves as an attractive site for covalent drug design. Many antimicrobial and antiviral agents, such as Nirmatrelvir, function by forming a stable bond with this residue, thereby inactivating the enzyme (Owen et al., 2021). However, a significant challenge in targeting these enzymes is achieving selectivity to avoid cross-reactivity with human cysteine-containing proteins like cathepsins or caspases. Such off-target interactions could lead to adverse side effects or systemic toxicity (McKerrow et al., 2009). Despite these challenges, this class of enzymes remains a cornerstone of drug discovery efforts for treating infectious diseases.

Other names
Cysteine-dependent microbial enzymesThiol-based microbial enzymesMicrobial cysteine proteasesCysteine-centered catalytic proteins
02

Mechanism of action

Covalent inhibition of the active-site cysteine thiol group, leading to irreversible or reversible inactivation of the enzyme.

03

Biological functions

Viral polyprotein processingBacterial cell wall synthesisPathogen virulenceNutrient acquisitionRedox homeostasis
04

Disease associations

InfectionCOVID-19MalariaChagas diseasePeriodontitis
05

Safety considerations

Off-target inhibition of human cysteine proteases (e.g., cathepsins, caspases)Potential for covalent adduct-induced toxicityDevelopment of drug resistance via active-site mutations
06

Interacting drugs

Nirmatrelvir

4 more in the full profile.

07

Biomarkers

Viral loadBacterial colony forming units (CFU)Enzymatic activity levelsCleavage product concentration

Beyond the preview

Go deeper on Microbial enzymes containing reactive cysteine residues.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbial enzymes containing reactive cysteine residues.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call